|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1Division of Basic Biomedical Sciences, Sanford School of Medicine, University of South Dakota, Vermillion, South Dakota; and 2Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland
Submitted 21 June 2007 ; accepted in final form 29 November 2007
Suppressed parasympathetic nervous system (PSNS) function has been found in a variety of cardiovascular diseases, such as hypertension, heart failure, and diabetes. However, whether impaired PSNS function plays a significant role in ventricular dysfunction remains to be investigated. Cardiac regulation by the PSNS is primarily mediated by the M2 muscarinic acetylcholine receptor (M2-AChR). In this study, we tested the hypothesis that lack of M2-AChR-mediated PSNS function may adversely impact cardiac ventricular function. Using M2-AChR knockout (KO) and wild-type (WT) mice, we found that the basal levels of heart rate and left ventricular function were similar in M2-AChR KO and WT mice. A bolus injection of isoproterenol (Iso) induced a greater increase in heart rate in M2-AChR KO mice than in WT mice. However, the responses of change in pressure over time (dP/dt) to Iso were similar in the two groups. After chronic infusion with Iso for 1 wk, the baseline values of left ventricular function were increased to similar extents in M2-AChR KO and WT mice. However, the M2-AChR KO mice exhibited impaired ventricular function, indicated as attenuated dP/dt and increased end-diastolic pressure, during an increase in cardiac afterload induced by a bolus injection of phenylephrine. Furthermore, chronic Iso infusion significantly increased matrix metalloproteinase (MMP) activity in the heart in M2-AChR KO mice. In primary culture of mixed neonatal rat cardiac fibroblast and cardiomyocytes, cotreatment with muscarinic agonist bethanechol reversed phenylephrine-induced increase in MMP-9 activation. These data suggest that M2-AChR may mediate an inhibitory regulation on MMP function. The overall results from this study suggest that M2-AChR-mediated PSNS function may provide cardiac protection. Lack of this protective mechanism will increase the susceptibility of the heart to cardiac stresses.
muscarinic; cardiac; contractility; matrix metalloproteinase; isoproterenol
This article has been cited by other articles:
![]() |
A. Lara, D. D. Damasceno, R. Pires, R. Gros, E. R. Gomes, M. Gavioli, R. F. Lima, D. Guimaraes, P. Lima, C. R. Bueno Jr., et al. Dysautonomia Due to Reduced Cholinergic Neurotransmission Causes Cardiac Remodeling and Heart Failure Mol. Cell. Biol., April 1, 2010; 30(7): 1746 - 1756. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Rudic and D. J. Fulton Pressed for time: the circadian clock and hypertension J Appl Physiol, October 1, 2009; 107(4): 1328 - 1338. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Steele, K. H. A. Lo, V. W. T. Li, S. H. Cheng, M. Ekker, and S. F. Perry Loss of M2 muscarinic receptor function inhibits development of hypoxic bradycardia and alters cardiac {beta}-adrenergic sensitivity in larval zebrafish (Danio rerio) Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2009; 297(2): R412 - R420. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |